Pfizer to seek FDA approval for Lyme disease vaccine candidate despite trial miss - CNBC

Pfizer to seek FDA approval for Lyme disease vaccine candidate despite trial miss - CNBC
4 stocks to watch on Friday: PM, PFE, MSTR, HIMS
Pfizer says once-a-month weight-loss drug works as it forecasts profit decline
Stocks making the biggest moves premarket: Palantir Technologies, Merck, Pfizer & more - CNBC
Pfizer says obesity injection shows promise as monthly treatment in mid-stage trial - CNBC
147.96BUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NYSE
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US7170811035
CUSIP
717081103
Sector
Healthcare
Industry
Drug Manufacturers - General
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
19.82
PEG Ratio
13.77
Book Value
15.21
Dividend Share
1.72
Dividend Yield
6.65%
Earnings Share
1.31
Wall Street Target Price
29.11
EPS Estimate Current Year
2.97
EPS Estimate Next Year
2.84
EPS Estimate Current Quarter
0.7217
EPS Estimate Next Quarter
0.6802
Most Recent Quarter
-
Revenue TTM
63,315,001,344
Gross Profit TTM
47,360,000,000
EBITDA
25,460,000,768
Profit Margin
11.83%
Return On Assets TTM
5.69%
Return On Equity TTM
8.31%
Revenue Per Share TTM
11.133
Qtly Revenue Growth YOY
5.40%
Diluted Eps TTM
1.31
Qtly Earnings Growth YOY
-10.10%
Trailing PE
19.82
Forward PE
8
Price Sales TTM
2.3368
Price Book MRQ
1.6244
Enterprise Value Revenue
3
Enterprise Value EBITDA
11
145.75
1.28%410.00
0.34%423.19
0.16%51.28
0.04%181.58
-1.85%111.43
-1.75%226.90
-1.68%148.08
-1.29%209.68
-0.53%1003.28
-0.42%Curated watchlists where PFE is featured.